Treatment sequences and drug costs from diagnosis to death in multiple myeloma
Last Updated: Thursday, November 16, 2023
This retrospective study analyzed treatment sequences and drug costs from 96 multiple myeloma patients in the Netherlands who died between January 2017 and July 2019. With sizeable end-of-life treatment costs resulting in limited survival benefits, this study can be used as a reference point for future cost studies.
Advertisement
News & Literature Highlights